Memphasys Limited (ASX:MEM)

Australia · Delayed Price · Currency is AUD

0.0050

0.00 (0.00%)

Oct 9, 2026, 3:53 PM AEST

Market Cap	15.44M +72.2%
Revenue (ttm)	657.97K +24.9%
Net Income	-4.10M
EPS	-0.00
Shares Out	3.09B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,332
Open	0.0050
Previous Close	0.0050
Day's Range	0.0050 - 0.0050
52-Week Range	0.0030 - 0.0090
Beta	0.50
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 26, 2026

About Memphasys

Memphasys Limited develops, manufactures, and sells cell and protein separation devices, and related consumables for the healthcare, veterinary, and biotechnology market sectors in Australia. The company offers Felix system, a device separates sperm from raw semen by electrophoresis process and size exclusion membranes. It also provides RoXsta, an in-vitro diagnostic device; and AI-Port, an ambient temperature semen transport device for artificial insemination in animals. In addition, the company develops ambient temperature storage product for... [Read more]

Industry Medical Devices

Sector Healthcare

Founded 2006

Employees 24

Stock Exchange Australian Securities Exchange

Ticker Symbol MEM

Full Company Profile

Financial Performance

In fiscal year 2026, Memphasys's revenue was 657,968, an increase of 24.87% compared to the previous year's 526,921. Losses were -4.10 million, -18.57% less than in 2025.

Financial Statements